Tarsons Products Limited Receives Credit Rating Reaffirmation from CARE
Tarsons Products Limited received credit rating reaffirmation from CARE for bank facilities totaling ₹612.73 crores. The rating agency maintained CARE A; Stable for long-term facilities and CARE A1 for short-term facilities. Notable changes include reduction in long-term facilities from ₹516.02 crores to ₹500.73 crores and enhancement of short-term facilities from ₹39.00 crores to ₹84.00 crores, along with assignment of new ₹4.00 crores short-term facilities.

*this image is generated using AI for illustrative purposes only.
Tarsons Products Limited has announced that CARE has reaffirmed the credit ratings for its bank loan facilities through a press release dated March 30, 2026. The company informed stock exchanges about this development on March 31, 2026, in compliance with SEBI listing regulations.
Credit Rating Details
CARE has maintained stable ratings across all facility categories for Tarsons Products. The rating reaffirmation covers total bank facilities worth ₹612.73 crores across different categories.
| Facilities | Amount (₹ crores) | Rating | Rating Action |
|---|---|---|---|
| Long Term Bank Facilities | 500.73 (Reduced from 516.02) | CARE A; Stable | Reaffirmed |
| Long-Term/Short-Term Bank Facilities | 24.00 (Reduced from 25.00) | CARE A; Stable / CARE A1 | Reaffirmed |
| Short-Term Bank Facilities | 4.00 | CARE A1 | Assigned |
| Short-Term Bank Facilities | 84.00 (Enhanced from 39.00) | CARE A1 | Reaffirmed |
Facility Amount Changes
The rating reaffirmation came with notable changes in facility amounts. Long-term bank facilities were reduced from ₹516.02 crores to ₹500.73 crores, representing a decrease of ₹15.29 crores. Similarly, the long-term/short-term bank facilities saw a marginal reduction from ₹25.00 crores to ₹24.00 crores.
Conversely, short-term bank facilities were significantly enhanced from ₹39.00 crores to ₹84.00 crores, more than doubling the available facility amount. The company also received a new assignment of ₹4.00 crores in short-term bank facilities with a CARE A1 rating.
Regulatory Compliance
The announcement was made pursuant to Regulation 30 read with Schedule III of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. Santosh Kumar Agarwal, who serves as CFO, Company Secretary and Compliance Officer, signed the regulatory filing. The company has also made this information available on its website at www.tarsons.com for stakeholder reference.
Historical Stock Returns for Tarsons Products
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +8.06% | +1.12% | -5.72% | -41.05% | -49.22% | -78.02% |
What strategic initiatives might Tarsons Products pursue with the significantly increased short-term facility allocation of ₹84 crores?
How could the reduction in long-term facilities impact Tarsons' capital expenditure plans and expansion projects over the next 2-3 years?
Will the shift from long-term to short-term facilities affect Tarsons' working capital management and operational flexibility?


































